These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28850001)

  • 1. Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials.
    Bonter K; Breckenridge Z; Lachance S; Delisle JS; Bubela T
    Regen Med; 2017 Sep; 12(6):623-636. PubMed ID: 28850001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials.
    Catani JPP; Riechelmann RP; Adjemian S; Strauss BE
    Hum Vaccin Immunother; 2017 May; 13(5):1109-1111. PubMed ID: 28059608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives.
    Bisson I; Green E; Sharpe M; Herbert C; Hyllner J; Mount N
    Regen Med; 2015; 10(2):169-79. PubMed ID: 25835481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the clinical impact of biomaterials in cancer immunotherapy.
    Gammon JM; Dold NM; Jewell CM
    Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical challenges facing therapeutic cancer vaccines.
    Ward S; Copier J; Dalgleish A
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):168-77. PubMed ID: 18283604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.
    Garg AD; Coulie PG; Van den Eynde BJ; Agostinis P
    Trends Immunol; 2017 Aug; 38(8):577-593. PubMed ID: 28610825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging immunotherapies in ovarian cancer.
    Ojalvo LS; Nichols PE; Jelovac D; Emens LA
    Discov Med; 2015 Sep; 20(109):97-109. PubMed ID: 26463091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.
    Ceppi F; Beck-Popovic M; Bourquin JP; Renella R
    Eur J Pediatr; 2017 Sep; 176(9):1163-1172. PubMed ID: 28803259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell transfer and other immunotherapeutic strategies.
    Rosenberg SA
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):28-9. PubMed ID: 16166964
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy for the treatment of breast cancer.
    Ernst B; Anderson KS
    Curr Oncol Rep; 2015 Feb; 17(2):5. PubMed ID: 25677118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy: new insights].
    Geissler M; Weth R
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise.
    Tenuta A; Klotz L; Parker JL
    BJU Int; 2014 May; 113(5b):E82-9. PubMed ID: 24053150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the immune system for cancer therapy.
    Smith EL; Zamarin D; Lesokhin AM
    Curr Opin Oncol; 2014 Nov; 26(6):600-7. PubMed ID: 25250678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [At the crossroads of cancer].
    Chouaib S
    Bull Cancer; 2013 Jun; 100(6):569-74. PubMed ID: 23735599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy: breaking the barriers to harvest the crop.
    Pardoll D; Allison J
    Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.